Controversies in the management of central nervous system leukemia

Pediatric Hematology and Oncology

Volumn 27, Issue 5, 2010, Pages 329-332

  Barredo, Julio ^a   Ritchey, A Kim ^b  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^b CHILDREN S HOSPITAL OF PITTSBURGH   (United States)

Author keywords

acute lymphoblastic leukemia; central nervous system relapse

Indexed keywords

ACUTE LYMPHOBLASTIC LEUKEMIA; CANCER RADIOTHERAPY; CANCER RELAPSE; CENTRAL NERVOUS SYSTEM LEUKEMIA; GENE EXPRESSION PROFILING; GENOTYPE; HUMAN; NOTE; PHARMACOGENETICS;

CENTRAL NERVOUS SYSTEM NEOPLASMS; CHEMOPREVENTION; DISEASE MANAGEMENT; HUMANS; PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA; RECURRENCE;

EID: 77955110799     PISSN: 08880018     EISSN: 15210669     Source Type: Journal    
DOI: 10.3109/08880011003758422     Document Type: Note

References (16)

1. Mahmoud HH, Rivera GK, Hancock ML, et al. Low leukocyte counts with blast cells in cerebrospinal fluid of children with newly diagnosed acute lymphoblastic leukemia. N Engl J Med. 1993;329:314-319.
2. Gilchrist GS, Tubergen DG, Sathere HN, et al. Low numbers of CSF blasts at diagnosis do not predict for the development of CNS leukemia in children with intermediate-risk acute lymphoblastic leukemia: a Childrens Cancer Group Report. J Clin Oncol. 1994;12:2594-2600.
3. Bürger B, Zimmermann M, Mann G, et al. Diagnostic cerebrospinal fluid examination in children with acute lymphoblastic leukemia: significance of low leukocyte counts with blasts or traumatic lumbar puncture. J Clin Oncol. 2003;21:184-188.
4. te Loo DMWM, Kamps WA, Van Den Berg A, et al. Prognostic significance of blasts in the cerebrospinal fluid without pleocytosis or a traumatic lumbar puncture in children with acute lymphoblastic leukemia: experience of the Dutch Childhood Oncology Group. J Clin Oncol. 2006;24:2332-2336.
5. Gajjar A, Harrison PL, Sandlund JT, et al. Traumatic lumbar puncture at diagnosis adversely affects outcome in childhood acute lymphoblastic leukemia. Blood. 2000;96:3381-3384.
6. Pui CH, Campana D, Pei D, et al. Treating childhood acute lymphoblastic leukemia without cranial irradiation. N Engl J Med. 2009;360:2730-2741.
7. Veerman AJ, Kamps WA, Van Den Berg H, et al. Dexamethasone-based therapy for childhood acute lymphoblastic leukaemia: results of the prospective Dutch Childhood Oncology Group (DCOG) protocol ALL-9 (1997-2004). Lancet Oncol. 2009;10:957-966.
8. Ritchey AK, Pollock BH, Lauer SJ, et al. Improved survival of children with isolated CNS relapse of acute lymphoblastic leukemia: a pediatric oncology group study. J Clin Oncol. 1999;17:3745-3752.
9. Barredo JC, Devidas M, Lauer SJ, et al. Isolated CNS relapse of acute lymphoblastic leukemia treated with intensive systemic chemotherapy and delayed CNS radiation: a pediatric oncology group study. J Clin Oncol. 2006;24:3142-3149.
10. Eapen M, Zhang MJ, Devidas M, et al. Outcomes after HLA-matched sibling transplantation or chemotherapy in children with acute lymphoblastic leukemia in a second remission after an isolated central nervous system relapse: a collaborative study of the Childrens Oncology Group and the Center for International Blood and Marrow Transplant Research. Leukemia. 2008;22:281-286.
11. Hagedorn N, Acquaviva C, Fronkova E, et al. Submicroscopic bone marrow involvement in isolated extramedullary relapses in childhood acute lymphoblastic leukemia: a more precise definition of "isolated" and its possible clinical implications, a collaborative study of the Resistant Disease Committee of the International BFM study group. Blood. 2007;110:4022-4029.
12. Buonamici S, Trimarchi T, Ruocco MG, et al. CCR7 signalling as an essential regulator of CNS infiltration in T-cell leukaemia. Nature. 2009;459:1000-1004.
13. Cannizzo E, Carulli G, Buda G, et al.Meningeal relapse in a case of B acute lymphoblastic leukemia: the role of CD56 expression. Med Sci Monit. 2009;15:CS27-CS22.
14. Cario G, Izraeli S, Teichert A, et al. High interleukin-15 expression characterizes childhood acute lymphoblastic leukemia with involvement of the CNS. J Clin Oncol. 2007;25:4813-4820.
15. Jeha S, Pei D, Raimondi SC, Onciu M, et al. Increased risk for CNS relapse in pre-B cell leukemia with the t(1;19)/TCF3-PBX1. Leukemia. 2009;23:1406-1409.
16. Rocha JC, Cheng C, Liu W, et al. Pharmacogenetics of outcome in children with acute lymphoblastic leukemia. Blood. 2005;105:4752-4758.